Showing results (71-80 of 267) with videos related to

Sort By:
Pageof 27
European Journal of Haematology|December 4, 2018
Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimenJuan Montoro, Jaime Sanz, José I Lorenzo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 3, 2007
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropeniaFernando Rivera, María E Vega-Villegas, Marta F López-Brea, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational StudyJosé Luis Piñana, Ariadna Pérez, Juan Montoro, et al.
Bone Marrow Transplantation|May 30, 2023
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 5, 2020
Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantationAriadna Pérez, Juan Montoro, Rafael Hernani, et al.
Bone Marrow Transplantation|May 7, 2020
Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donorsJuan Montoro, José Luis Piñana, Juan C Hernández-Boluda, et al.
International Journal of Environmental Research and Public Health|July 27, 2022
Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or SarcopeniaJaime Sanz-Cánovas, Almudena López-Sampalo, Lidia Cobos-Palacios, et al.
Bone Marrow Transplantation|February 2, 2022
Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMTArnon Nagler, Myriam Labopin, Xiao-Jun Huang, et al.
Bone Marrow Transplantation|December 2, 2022
Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Transplantation and Cellular Therapy|January 22, 2023
T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic AnemiaPedro Chorão, Juan Montoro, Aitana Balaguer-Roselló, et al.
Pageof 27